Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Avian cell – per se
Reexamination Certificate
2011-06-21
2011-06-21
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Avian cell, per se
C424S093600, C424S093700, C424S184100, C424S232100, C424S281100, C435S041000, C435S070100, C435S235100, C435S239000, C435S384000
Reexamination Certificate
active
07964397
ABSTRACT:
The present invention relates to a method for the cultivation of primary cells. The primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. The method for the cultivation of primary cells may be one step in a method for the amplification of viruses, such as poxviruses. According to this latter method the primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. The cells are then infected with the virus and the infected cells are cultivated in serum free medium until progeny virus is produced.
REFERENCES:
patent: 3887430 (1975-06-01), Torney et al.
patent: 4072565 (1978-02-01), Weiss et al.
patent: 5024947 (1991-06-01), Inlow et al.
patent: 5155020 (1992-10-01), Paoletti
patent: 5185146 (1993-02-01), Altenburger et al.
patent: 5403582 (1995-04-01), Nazerian et al.
patent: 5405772 (1995-04-01), Ponting
patent: 5494807 (1996-02-01), Paoletti et al.
patent: 5550051 (1996-08-01), Mundt et al.
patent: 5753489 (1998-05-01), Kistner et al.
patent: 5756341 (1998-05-01), Kistner et al.
patent: 5789245 (1998-08-01), Dubensky et al.
patent: 6100061 (2000-08-01), Reiter et al.
patent: 6146873 (2000-11-01), Kistner et al.
patent: 6761893 (2004-07-01), Chaplin et al.
patent: 6913752 (2005-07-01), Chaplin et al.
patent: 6924137 (2005-08-01), Howley et al.
patent: 7056723 (2006-06-01), Heller et al.
patent: 7097842 (2006-08-01), Suter et al.
patent: 7189536 (2007-03-01), Chaplin et al.
patent: 7335364 (2008-02-01), Chaplin et al.
patent: 7384644 (2008-06-01), Chaplin et al.
patent: 7445924 (2008-11-01), Chaplin et al.
patent: 7695939 (2010-04-01), Rathe et al.
patent: 2002/0022268 (2002-02-01), Xu et al.
patent: 2003/0013190 (2003-01-01), Mayr
patent: 2003/0228330 (2003-12-01), Falkner et al.
patent: 2004/0058441 (2004-03-01), Pain et al.
patent: 2004/0234950 (2004-11-01), Howley et al.
patent: 2005/0214323 (2005-09-01), Chaplin et al.
patent: 2005/0214324 (2005-09-01), Rathe et al.
patent: 2006/0093620 (2006-05-01), Falkner et al.
patent: 2006/0127984 (2006-06-01), Ackermann et al.
patent: 2006/0280758 (2006-12-01), Chaplin et al.
patent: 2008/0089907 (2008-04-01), Chaplin et al.
patent: 2010/0111999 (2010-05-01), Guehenneux et al.
patent: 0584788 (1994-03-01), None
patent: H9-154571 (1997-06-01), None
patent: WO 92/05246 (1992-04-01), None
patent: 95/22978 (1995-08-01), None
patent: WO96/15231 (1996-05-01), None
patent: WO 97/02355 (1997-01-01), None
patent: WO 97/31119 (1997-08-01), None
patent: WO98/04680 (1998-02-01), None
patent: WO 98/04680 (1998-02-01), None
patent: WO 98/15614 (1998-04-01), None
patent: WO98/15614 (1998-04-01), None
patent: WO 98/56919 (1998-12-01), None
patent: WO 99/07869 (1999-02-01), None
patent: WO 00/28016 (2000-05-01), None
patent: WO 00/29428 (2000-05-01), None
patent: WO 01/68820 (2001-09-01), None
patent: WO 01/89559 (2001-11-01), None
patent: WO 02/24224 (2002-03-01), None
patent: WO02/24876 (2002-03-01), None
patent: WO 02/42480 (2002-05-01), None
patent: WO03/008533 (2003-01-01), None
patent: 03/054175 (2003-07-01), None
patent: WO03/054174 (2003-07-01), None
Balk et al., Epidermal growth factor and insulin cause normal chicken heart mesenchymal cells to proliferate like their Rous sarcoma virus-infected counterparts, Proc. Nat. Acad. Sci. USA 79: 1154-1157 (1982).
Couchman et al.,Fibronectin Has a Dual Role in Locomotion and Anchorage of Primary Chick Fibroblasts and Can Promote Entry into the Division Cycle, J. Cell. Biol. 93: 402-410 (1982).
Kwon et al., Test on Growth and Maintenance Examination of Chick Embryo Fibroblast in the Medium to Which Chicken Embryo Amnio-Allantoic Fluid is Added Instead of Bovine Serum, Agriculture Test Research Report No. 20 (Livestock Hygiene Sericulture Section): 5-9 (1978).
Nakamura et al., Tyrosine Phosphorylation of Specific Proteins After Mitogen Stimulation of Chicken Embryo Fibroblasts, Mol. Cell Biol. 3:380-390 (1983).
Pietrzkowski et al., Cellular Activities Associated with the Transition of Chick Embryo Fibroblasts from Stationary to Proliferation State, Folia Histochemica et Cytobiologica vol. 27:183-196 (1969).
Price et al., Serum-Free Medium Without Animal Components for Virus Production, FOCUS vol. 19 No. 3, 67-69 (1997).
Zell- Und Gewebekultur, Einführung in die Grundiagen sowie ausgewählte Methoden und Anwendungen, Lindl et al., Gustav Fischer Verlag, Stuttgart, New York, p. 57 (1987).
Life Technologies, Product description of VP-SFM (May 1999).
Focus on Alternatives, Serum Free Media for Cell Culture (Aug. 2006).
Grob et al., Role of the Individual Interferon Systems and Specific Immunity in Mice in Controlling Systemic Dissemination of Attenuated Pseudorabies Virus Infection, 1999, Journal of Virology, vol. 73, No. 6, pp. 4748-4754.
Carroll, MW, and Moss, B. 1997, Virology 238:198-211.
Meyer, H, et al. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 1991, 72:1031-1038.
Marhoul, Z, et al. Cultivation of Lednice (Yaba1) virus in goose, duck and chick embryo cells. 1976, Acta Virol. 20:499-505. (Abstract).
Ivanov, I, et al. Propagation of avian pox virus vaccine strains in duck embryo cell line—Dec. 99, 2001, Experimental Pathology and Parasitology 4/6, pp. 46-49.
Asher D.M., Bovine Sera Used in the Manufacture of Biologicals: Current Concerns and Policies of the U.S. Food and Drug Administration Regarding the Transmissible Spongiform Encephalopathies, 1999, Developments in Biological Standardization, vol. 99, pp. 41-44.
Kozak et al., Transmissible Spongiform Encephalopathies (TSE): Minimizing the Risk of Transmission of Biological/ Biopharmaceutical Products: an Industry Perspective, 1996, Developments in Biological Standardization, vol. 88, pp. 257-264.
Pietrzkowski, et al. “Dextran 1-500 improves survival and spreading of chick embryo cells in serum-free medium” Folia Histochemica et Cytobiologica, vol. 26 No. 3, 1988, p. 123-132.
Stittelaar, et al., Vaccine 19: 3700-3709, 2001.
Sutter and Moss, Proc. Natl. Acad. Sci. USA 89:10847-51, 1992.
Schiefiinger, et al., Proc. Natl. Acad. Sci. USA 89:9977-81, 1992.
Merchlinsky, et al., Virology 190:522-6, 1992.
Moss, et al. “Host range restricted, non-replicating vaccinia vires vectors as vaccine candidates.” Advances in Experimentaly Medicine and Biology, 397:7-13, 1996.
Wyatt, et al., PNAS 101:4590-4595, 2004.
Earl, et al., Nature 428: 182-185, 2004.
A. Mayr, ZBL Vet B 23, 417-430 (1976).
Blanchard, JT, et al., Journal of General Virology, 79, 1159-1167, 1998.
Bender, et al. Journal of Virology, vol. 70, No. 9, pp. 6418-6424, 1996.
Schneider, et al. Nature Medicine, 4, 397-402, 1998.
Sutter, et al. Vaccine 12, 1032-1040, 1994.
Eo, et al., The Journal of Immunology 166: 54735479, 2001.
Holzer, et al., Journal of Virology 73: 4536-4542, 1998.
Antoine, et al., Virology 244: 365-396, 1998.
Gilbert, et al., Biol. Chem. 380: 299-303, 1999.
Behera, et al., Hum. Gene Ther. 13 (14): 1697-709, 2002.
Belyakov, et al., Proc. Natl. Acad. Sci. 100: 9458-9463, 2003.
Hanke, et al., Journal of Virology 73: 7524-7532, 1999.
Bitterman et al., Role of fibronectin as a growth factor for fibroblasts, Journal of Cell Biology 97:1925-1932, 1983.
Clark et al., Serum supplements and serum-free media: applicability for microcarrier culture of animal cells, Developments in Biological Standardization 50:81-91, 1981.
Iding et al., An automatic system for the assessment of complex medium additives under cultivation conditions, Biotechnology and Bioengineering 73:442-448, 2001.
Vettese-Dadey M, One to Grow on, The Scientist 13:20, 1999.
Hundt et al., Serum free cultivation of primary embryo fibroblasts in microcarrier systems for vaccine production, Animal Cell Technology Meets Genomics, 771-774, 2005.
Gilbert et al, Current status for high titre poxvirus stock preparation in CEF under serum-free conditions: implications for vaccine development, Cytotechnology 28:79-88, 2005.
Geistlich a
Felder Eva
Heller Karl
Rathe Ingmar
Bavarian Nordic A/S
Blumel Benjamin P
Law Office of Salvatore Arrigo and Scott Lee, LLP
Lucas Zachariah
LandOfFree
Method for the cultivation of primary cells and for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the cultivation of primary cells and for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the cultivation of primary cells and for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2741031